| 2024-01-24 |
复牌提示：
2024-01-23 19:50:00 停牌，复牌日期 2024-01-25 00:00:01
|
| 2024-01-24 |
详情>>
内部人交易：
Dunoyer Marc等共交易6笔
|
| 2023-11-16 |
股东大会：
将于2023-12-19召开股东大会
会议内容 ▼▲
- 1.Amendment of the Articles of Association and General Authorisation to Carry Scheme into Effect.THAT, for the purpose of giving effect to the scheme of arrangement dated November 16, 2023 between Orchard and the holders of Scheme Shares (as defined in such scheme of arrangement), a print of which has been produced to this meeting and for the purposes of identification signed by the Chair of this meeting, in its original form or with or subject to any modification, addition, or condition as may be agreed from time to time (including, for the avoidance of doubt, after the date of this resolution) between Orchard and Kyowa Kirin Co., Ltd (“KKC”) which (if required) is approved by the High Court of Justice of England and Wales (the “Court”), or which is otherwise imposed by the Court and is mutually acceptable to Orchard and KKC each acting reasonably and in good faith (the “Scheme”):(A)the directors of Orchard (or a duly authorized committee of the directors) be and are hereby authorized to take all such action as they may consider necessary or appropriate for carrying the Scheme into effect;(B)with effect from the passing of this resolution, the articles of association of Orchard be and are hereby amended by the adoption and inclusion of the following new article 143.
2.Non-Binding Advisory Proposal to Approve Certain Compensation Arrangements.THAT, the compensation that may be paid or become payable to Orchard’s named executive officers in connection with the Transaction, as disclosed in the table entitled “Potential Payments to Named Executive Officers” beginning on page 83 of the accompanying proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable, are hereby approved.
|
| 2023-11-16 |
详情>>
股本变动：
变动后总股本2276.20万股
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.35美元,归母净利润-6503.8万美元,同比去年增长54.45%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.18美元,归母净利润-2971.9万美元,同比去年增长68.79%
|
| 2023-08-03 |
财报披露：
美东时间 2023-08-03 盘前发布财报
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-0.12美元,归母净利润-1741.2万美元,同比去年增长60.69%
|
| 2023-04-27 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.To re-elect James Geraghty as a director, who retires by rotation in accordance with the Company’s Articles of Association.
2.To re-elect Steven M. Altschuler as a director, who retires by rotation in accordance with the Company’s Articles of Association.
3.To re-elect Marc Dunoyer as a director, who retires by rotation in accordance with the Company’s Articles of Association.
4.To re-appoint PricewaterhouseCoopers LLP, a United Kingdom entity, as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
5.To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership, as the Company’s independent registered public accounting firm, for the fiscal year ending December 31, 2023.
6.To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the fiscal year ending December 31, 2023.
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2022 and to note that the Company’s directors do not recommend the payment of any dividend for the year ended December 31, 2022.
8.To approve the compensation of the Company’s named executive officers for the year ended December 31, 2022 on a non-binding, advisory basis.
9.To receive and approve the Company’s U.K. statutory directors’ remuneration report for the year ended December 31, 2022 on a non-binding, advisory basis, which is set forth as Annex A to the attached proxy statement.
10.To authorize the Board of Directors, generally and unconditionally for the purpose of s551 of the U.K. Companies Act 2006, to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to a maximum aggregate nominal amount of ￡18,398,450.
|
| 2023-03-14 |
详情>>
业绩披露：
2022年年报每股收益-1.18美元,归母净利润-1.51亿美元,同比去年增长-4.2%
|
| 2023-03-10 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.12美元,归母净利润-1.43亿美元,同比去年增长-31.91%
|
| 2022-08-04 |
详情>>
业绩披露：
2022年中报每股收益-0.75美元,归母净利润-9521.2万美元,同比去年增长-32.62%
|
| 2022-05-12 |
详情>>
业绩披露：
2022年一季报每股收益-0.35美元,归母净利润-4429.6万美元,同比去年增长-25.91%
|
| 2022-04-27 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.To re-elect as a director John T. Curnutte, who retires by rotation in accordance with the Company’s Articles of Association.
2.To re-elect as a director Bobby Gaspar, who retires by rotation in accordance with the Company’s Articles of Association.
3.To re-elect as a director Alicia Secor, who retires by rotation in accordance with the Company’s Articles of Association.
4.To re-appoint PricewaterhouseCoopers LLP, a United Kingdom entity, as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
5.To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership, as the Company’s independent registered public accounting firm, for the fiscal year ending December 31, 2022.
6.To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the fiscal year ending December 31, 2022.
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2021 and to note that the Company’s directors do not recommend the payment of any dividend for the year ended December 31, 2021.
8.To approve the compensation of the Company’s named executive officers for the year ended December 31, 2021 on a non-binding, advisory basis.
9.To receive and approve the Company’s U.K. statutory directors’ remuneration report for the year ended December 31, 2021 on a non-binding, advisory basis, which is set forth as Part II of Annex A to the attached proxy statement.
10.To approve the Company’s U.K. directors’ remuneration policy, which is set forth as Part I of Annex A to the attached proxy statement and which, if approved, will take effect upon the conclusion of the Annual General Meeting.
|
| 2022-03-30 |
详情>>
业绩披露：
2021年年报每股收益-1.17美元,归母净利润-1.45亿美元,同比去年增长4.87%
|
| 2021-11-04 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.88美元,归母净利润-1.08亿美元,同比去年增长8.55%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-04 |
详情>>
业绩披露：
2021年中报每股收益-0.6美元,归母净利润-7179.1万美元,同比去年增长26.80%
|
| 2021-04-28 |
股东大会：
将于2021-06-16召开股东大会
会议内容 ▼▲
- 1.To re-elect as a director Charles A. Rowland, Jr., who retires by rotation in accordance with the Company’s Articles of Association.
2.To re-elect as a director Joanne T. Beck, who retires by rotation in accordance with the Company’s Articles of Association.
3.To re-appoint PricewaterhouseCoopers LLP, a United Kingdom entity, as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
4.To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership, as the Company’s independent registered public accounting firm, for the fiscal year ending December 31, 2021.
5.To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the fiscal year ending December 31, 2021.
6.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2020 and to note that the Company’s directors do not recommend the payment of any dividend for the year ended December 31, 2020.
7.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2020.
8.To receive and approve on an advisory basis the Company’s U.K. statutory directors’ remuneration report for the year ended December 31, 2020, which is set forth as Annex A to the attached proxy statement.
9.To authorize the Board of Directors, generally and unconditionally for the purpose of s551 of the U.K. Companies Act 2006 to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to a maximum aggregate nominal amount of ￡13,023,851.50. This authority shall expire (unless previously renewed, varied or revoked) on June 15, 2026, but the Company may at any time before the expiration of this authority make an offer or agreement which would or might require shares to be allotted, or Rights to be granted, pursuant to this authority after its expiration, and the Board of Directors may allot shares or grant Rights in pursuance of that offer or agreement as if the authority conferred by this resolution had not expired.
|
| 2020-04-29 |
股东大会：
将于2020-06-17召开股东大会
会议内容 ▼▲
- 1.To re-elect as a director Steven M. Altschuler, who retires by rotation in accordance with the Company’s Articles of Association.
2.To re-elect as a director Marc Dunoyer, who retires by rotation in accordance with the Company’s Articles of Association.
3.To re-elect as a director James Geraghty, who retires by rotation in accordance with the Company’s Articles of Association.
4.To re-appoint PricewaterhouseCoopers LLP, a United Kingdom entity, as U.K. statutory auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
5.To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership, as the Company’s independent registered public accounting firm, for the fiscal year ending December 31, 2020.
6.To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the fiscal year ending December 31, 2020.
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2019 and to note that the Company’s directors do not recommend the payment of any dividend for the year ended December 31, 2019.
8.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2019.
9.To indicate, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of the Company’s named executive officers.
10.To receive and approve the Company’s U.K. statutory directors’ remuneration report for the year ended December 31, 2019, which is set forth as Annex A to the attached proxy statement.
11.To authorize the Board of Directors, generally and unconditionally for the purpose of s551 of the U.K. Companies Act 2006 to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to a maximum aggregate nominal amount of ￡13,023,851.50. This authority shall expire (unless previously renewed, varied or revoked) on June 16, 2025, but the Company may at any time before the expiration of this authority make an offer or agreement which would or might require shares to be allotted, or Rights to be granted, pursuant to this authority after its expiration, and the Board of Directors may allot shares or grant Rights in pursuance of that offer or agreement as if the authority conferred by this resolution had not expired.
|
| 2019-06-03 |
股东大会：
将于2019-06-26召开股东大会
会议内容 ▼▲
- Ordinary Resolutions
1.To receive, consider and adopt the Directors’ and Auditors’ Reports and Statement of Accounts for the year ended 31 December 2018 and note that the Directors do not recommend payment of a dividend
2.To approve the Directors’ Remuneration Report
3.To approve the Directors’ Remuneration Policy
4.To elect Hubert Gaspar as a Director
5.To elect Alicia Secor as a Director
6.To re-appoint PricewaterhouseCoopers LLP as Auditor
7.To authorise the Directors to determine the Auditor’s remuneration
Special Resolutions
8.To authorise the Directors to allot shares pursuant to Section 551 of the Companies Act 2006 (the “Act”)
9.Subject to the passing of Resolution 8, to authorise the Directors to allot equity securities, under Section 570 of the Act as if Section 561(1) of the 2006 Act did not apply to such allotment
|